[治疗无塑性贫血的参考指南:2022年修订版的重点]
1Division of Transfusion Medicine, Kanazawa University Hospital.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 4, 2023
概括
修订后的无塑性贫血治疗指南建议早期将抗细胞球蛋白 (ATG) 与埃尔特罗姆波巴格 (EPAG) 结合起来. 它还更新了严重无形性贫血的选择,包括骨髓移植.
科学领域:
- 血液学 血液学 血液学
- 临床实践指南 临床实践指南
- 免疫抑制疗法 免疫抑制疗法
背景情况:
- 无质性贫血治疗指南需要根据不断发展的研究定期更新.
- 之前的指导方针缺乏针对新型组合疗法的具体建议.
研究的目的:
- 提出修订后的版本.
- 治疗无质性贫血的参考指南.
- , , , 这是一个很好的方法.
- 突出了关键的更新和新的建议.
主要方法:
- 根据最新的科学证据,对临床实践指南的修订.
- 制定临床问题,以应对当前的治疗挑战.
主要成果:
- 建议早期启动与抗血球球蛋白 (ATG) 和环素结合的埃尔特罗姆波巴格 (EPAG).
- 认为全基性骨髓移植对于患有严重无质性贫血和HLA匹配捐赠者的年轻人来说是一种选择,即使在初始免疫抑制治疗后也是如此.
- 涉及非严重病例的治疗,ATG剂量,年龄限制,感染预防和G-CSF使用.
结论:
- 更新的指南包含了支持EPAG和ATG联合治疗的证据.
- 重度无形性贫血的治疗策略得到了改进,将移植作为一种可行的选择.
- 在日本进行进一步的证据生成和临床试验对于推进无形性贫血治疗至关重要.
更多相关视频
10:48Isolation and Cryopreservation of Highly Viable Human Peripheral Blood Mononuclear Cells From Whole Blood: A Guide for Beginners
Published on: October 25, 2024
3.3K
08:32CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
3.6K
相关概念视频
Bone Marrow Sampling and Transplants
345
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
345
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Blood Transfusion
587
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
587
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
